|
|
Line 1,756: |
Line 1,756: |
| <img src="https://static.igem.org/mediawiki/2011/f/f8/Partnershipheader.png" height="75px" width="890px"> | | <img src="https://static.igem.org/mediawiki/2011/f/f8/Partnershipheader.png" height="75px" width="890px"> |
| <h2>Collaboration</h2> | | <h2>Collaboration</h2> |
- | <h3>Collaboration with Turk teams in iGEM 2011 </h3><br /> | + | <h3>Collaboration with Turkish teams in iGEM 2011 </h3><br /> |
| <br /> | | <br /> |
- | Since iGEM 2007, there is a team to research and prepare a project for iGEM competition from Middle East Technical University(METU). On behalf, there are advisors and instructors who are familiar with competition and content of it. In this year there are 4 registered teams from Turkey and 3 of them are new participants. Therefore in order to come together and criticize our projects and any deficiencies or ambugity related with project. So we organized and arranged a meeting on Synthetic Biology and iGEM competition which is the first in our country.The participants of this meeting were teams;<b>Fatih Turkey, Bilkent_UNAM, METU-BIN</b> and researchers who related with Synthetic Biology and company owners in Biotechnology field also there was special guests via online talk, Drew Endy, he is an assistant Professor of Bioengineering, Stanford University and Scott Mohr Professor of Biological Chemistry, Boston University This meeting was held in September 10, that was close to Regional Jamboree in order to also check the presentation preparations of teams. The news agencies were also invited and the interviews were done with all teams publicity of teams were enhanced. <br /> | + | Since iGEM 2007, there is a team to research and prepare a project for iGEM competition from Middle East Technical University(METU). On behalf, there are advisors and instructors who are familiar with competition and content of it. In this year there are 4 registered teams from Turkey and 3 of them are new participants. Therefore, in order to come together and criticize our projects and any deficiencies or ambugity related with project, we organized and arranged a meeting on Synthetic Biology and iGEM competition which is the first in our country.The participants of this meeting were teams;<b>Fatih Turkey, Bilkent_UNAM, METU-BIN</b> and researchers who related with Synthetic Biology and company owners in Biotechnology field also there was special guests via online talk, Drew Endy, he is an assistant Professor of Bioengineering, Stanford University and Scott Mohr Professor of Biological Chemistry, Boston University. This meeting was held in September 10, that was close to Regional Jamboree in order to also check the presentation preparations of teams. The news agencies were also invited and the interviews were done with all teams publicity of teams were enhanced. <br /> |
| <br /> | | <br /> |
| Except from this, we established a collaboration with <b>METU-BIN Software iGEM 2011</b> team on their software program. This year their project, <a href="http://dayhoff.ii.metu.edu.tr:8080/m4b/" target="_blank">M4B: Mining for BioBricks</a> is on enhancement and simplification of parts registry and gene library usage to ease the wet lab researchers job. They requested us to use and try their software program. One of our parts in this year, kill switch is composite of this year distributions. By the way we tried their program to search and try on this composite. we gave them the following as feedback and also according to our comments on visual of program, we had collaborated this year.<br /> | | Except from this, we established a collaboration with <b>METU-BIN Software iGEM 2011</b> team on their software program. This year their project, <a href="http://dayhoff.ii.metu.edu.tr:8080/m4b/" target="_blank">M4B: Mining for BioBricks</a> is on enhancement and simplification of parts registry and gene library usage to ease the wet lab researchers job. They requested us to use and try their software program. One of our parts in this year, kill switch is composite of this year distributions. By the way we tried their program to search and try on this composite. we gave them the following as feedback and also according to our comments on visual of program, we had collaborated this year.<br /> |
Line 2,229: |
Line 2,229: |
| <p><b>b. Risks to the safety and health of the general public if released by design or accident?</b></p> | | <p><b>b. Risks to the safety and health of the general public if released by design or accident?</b></p> |
| <ol> | | <ol> |
- | <li>The materials mentioned in part a. could potentially be dangerous to the general public. We use just enough concentration for our experiments. We always check the amount both for methane and methanol and EtBr, because if accidentally released, they could be dangerous to us while experiments and to lab security.</li> | + | <li>The materials mentioned in part a. could potentially be dangerous to the general public. We use just enough concentration for our experiments. We always check the amount both for methane and methanol and EtBr, because if accidentally released, |
- | </ol>
| + | |
- | <p><b>c. Risks to environmental quality if released by design or accident?</b></p>
| + | |
- | <ol>
| + | |
- | <li>Since methane is a gas at normal temperature and pressure, the inhalation of this gas pose a risk for human health and so for environmental quality. Methane is potent greenhouse gas and compared to carbon dioxide it has greater potential. This makes methane gas dangerous for environmental quality in case of release by accident or design.However, as mentioned in part a, we controlled the conditions for gas and examined in air ventilated glove boxes. Another material which could pose risk for environmental quality is methanol. This chemical is volatile and flammable liquid. When this chemical release near open flame it could result with harmful effects both for health and environment conditions.</li>
| + | |
- | </ol>
| + | |
- | <p><b> d. Risks to security through malicious misuse by individuals, groups or states?</b><br />
| + | |
- | <b><br />
| + | |
- | </b>Only the methane gas has risks for security if reaches to malicious someone. Our group members have experience and training on gas used experiments and there is no possibility on misuse indeed malicious misuse.<b></b><br />
| + | |
- | e.<b>Please explain your responses (whether yes or no) to these questions.<br />
| + | |
- | Specifically, are any parts or devices in your project associated with (or known to cause):</b><br />
| + | |
- | <b>- pathogenicity, infectivity, or toxicity? </b> No<b></b><br />
| + | |
- | <b>- threats to environmental quality? </b>None of our designed parts pose a risk to environment<b></b><br />
| + | |
- | <b>- security concerns? </b>No<b></b></p>
| + | |
- | <p> There are no part on our experiments and our project that could be use as treat to environment or infect to human life as individually. Only one of the parts, subunit A of methane monooxygenase may pose a health risk while studying since it has the region where methane interacts and the conversion steps initialize. As host cell we used E.coli BL21 (DE3) and Top10 strains, these strains are classified as hazard group 2 pathogen by the UK Advisory Committee on the Dangerous Pathogens (ACDP). <br />
| + | |
- | <b>2. If your response to any of the questions above is yes:</b><br />
| + | |
- | <b>a. Explain how you addressed these issues in project design and while conducting laboratory work. </b>Explained in each question<b></b><br />
| + | |
- | <b>b. Describe and document safety, security, health and/or environmental issues as you submit your parts to the Registry. </b>Explained in each question<b></b><br />
| + | |
- | <b><br />
| + | |
- | </b><br />
| + | |
- | <b>3. Under what biosafety provisions will / do you operate?</b><br />
| + | |
- | <b>a. Does your institution have its own biosafety rules and if so what are they? Provide a link to them online if possible.</b><br />
| + | |
- | Yes, there is general laboratory biosafety rules for lab security and researcher security obeyed in Biology and Chemistry departments. In research laboratories the students are provided with general lab security and rules which are compilation of general and international procedures for individual safety. These procedures are the compilation of several links as<br />
| + | |
- | <a href="http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Gdlnes_lnk_2002z.pdf" target="_blank">http://oba.od.nih.gov/oba/rac/guidelines_02/NIH_Gdlnes_lnk_2002z.pdf</a></p>
| + | |
- | <p> </p>
| + | |
- | <p><b>b. Does your institution have an Institutional Biosafety Committee or equivalent group? If yes, have you discussed your project with them? Describe any concerns or changes that were made based on this review.</b></p>
| + | |
- | <p>Yes there is biosafety and ethical research center in METU until 2000. This committee helds many conferences about ethics, environmental ethics in studies and the medicinal ethics based on human researchs. The below link belongs to this committee however in Turkish language.<br />
| + | |
- | <a href="http://www.ueam.metu.edu.tr/" target="_blank">http://www.ueam.metu.edu.tr</a></p>
| + | |
- | <p> Indeed in Biology department at METU one of our professors, Prof.Dr Huseyin Avni Oktem was one of the members of National Biosafety Coordinating Committee. He is our pioneer for biosafety and security issues. In the case of any safety issues, he is the one to consult the critical safety points in our project and also discussed the project based on safety. </p>
| + | |
- | <p><b> c. Will / did you receive any biosafety and/or lab training before beginning your project? If so, describe this training.</b></p>
| + | |
- | <p>Before we begin to experiments, we firstly were taught on lab security and personal safety for cases of individual injure, indeed in emergency situations. This interval was training for us. Also team leaders, the experienced ones in team, prepared an exam for new team members as a part of training for general lab regulations and project details.</p>
| + | |
- | <ol>
| + | |
- | <li><b>Does your country have national biosafety regulations or guidelines? If so, provide a link to them online if possible.</b></li>
| + | |
- | </ol>
| + | |
- | <p><b> </b></p>
| + | |
- | <p>In Turkey, biosafety regulations are organized by the Biosafety Information Exchange Mechanism of Turkey, facility of Ministry of Agriculture and Rural Affair.<br />
| + | |
- | <a href="http://www.tbbdm.gov.tr/en/Home.aspx" target="_blank">http://www.tbbdm.gov.tr/en/Home.aspx</a></p>
| + | |
- |
| + | |
- | </div>
| + | |
- | </div>
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="clear">
| + | |
- | </div>
| + | |
- | <!-- 7th row -->
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="clear">
| + | |
- | </div>
| + | |
- | <!-- 8th row -->
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="clear">
| + | |
- | </div>
| + | |
- | <!-- 9th row -->
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="clear">
| + | |
- | </div>
| + | |
- | <!-- 10th row -->
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="item">
| + | |
- | </div>
| + | |
- | <div class="clear">
| + | |
- | </div>
| + | |
- | <script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
| + | |
- | <div id="menu">
| + | |
- | <b><ul class="navmenu">
| + | |
- | <li>
| + | |
- | <div class="menutop menusingle panel">
| + | |
- | <a class="panel" href="#home">HOME</a>
| + | |
- | </div>
| + | |
- | </li>
| + | |
- | <li>
| + | |
- | <div class="menutop panel">
| + | |
- | <a class="panel" href="#project">PROJECT</a><div class="toggle toggle-closed">
| + | |
- | +</div>
| + | |
- | </div>
| + | |
- | <ul class="submenu">
| + | |
- | <li><a class="panel" href="#project2">Methane sensing</a></li>
| + | |
- | <li><a class="panel" href="#project3">Conversion</a></li>
| + | |
- | <li><a class="panel" href="#project4">Entrapment</a></li>
| + | |
- | <li><a class="panel" href="#project5">Killswitch</a></li>
| + | |
- |
| + | |
- | </ul>
| + | |
- | </li>
| + | |
- | <li>
| + | |
- | <div class="menutop menusingle panel">
| + | |
- | <a class="panel" href="#team">TEAM</a>
| + | |
- | </div>
| + | |
- | </li>
| + | |
- | <li>
| + | |
- | <div class="menutop panel">
| + | |
- | <a class="panel" href="#wetlab">WET LAB</a><div class="toggle toggle-closed">
| + | |
- | +</div>
| + | |
- | </div>
| + | |
- | <ul class="submenu">
| + | |
- | <li><a class="panel" href="#wetlab2">Lab Protocols</a></li>
| + | |
- | <li><a class="panel" href="#wetlab3">Biobricks</a></li>
| + | |
- | <li><a class="panel" href="#wetlab4">Notebook</a></li>
| + | |
- | <li><a class="panel" href="#wetlab5">Results</a></li>
| + | |
- | <li><a class="panel" href="#wetlab6">Safety</a></li>
| + | |
- | </ul>
| + | |
- | </li>
| + | |
- | <li>
| + | |
- | <div class="menutop panel">
| + | |
- | <a class="panel" href="#humanpractice">HUMAN PRACTICE</a><div class="toggle toggle-closed">
| + | |
- | +</div>
| + | |
- | </div>
| + | |
- | <ul class="submenu">
| + | |
- | <li><a class="panel" href="#humanpractice2">Online Lecture</a></li>
| + | |
- | <li><a class="panel" href="#humanpractice3">Public Awareness</a></li>
| + | |
- | <li><a class="panel" href="#humanpractice4">Media Press</a></li>
| + | |
- | <li><a class="panel" href="#humanpractice5">Fun & Learn</a></li>
| + | |
- |
| + | |
- | </ul>
| + | |
- | </li>
| + | |
- | <li>
| + | |
- | <div class="menutop menusingle panel">
| + | |
- | <a class="panel" href="#futureplan">FUTURE PLAN</a></div>
| + | |
- | </li>
| + | |
- | <li>
| + | |
- | <div class="menutop panel">
| + | |
- | <a class="panel" href="#partnership">PARTNERSHIP</a><div class="toggle toggle-closed">
| + | |
- | +</div>
| + | |
- | </div>
| + | |
- | <ul class="submenu">
| + | |
- | <li><a class="panel" href="#partnership2">Collaboration</a></li>
| + | |
- | <li><a class="panel" href="#partnership3">Sponsors</a></li>
| + | |
- | <li><a class="panel" href="#partnership4">METU</a></li>
| + | |
- | <li><a class="panel" href="#partnership5">Acknowledgements</a></li>
| + | |
- | </ul>
| + | |
- | </li>
| + | |
- | <li>
| + | |
- | <div class="menutop menusingle panel">
| + | |
- | <a class="panel" href="#extras"> EXTRAS</a>
| + | |
- | </div>
| + | |
- | </li>
| + | |
- | <li>
| + | |
- | <div class="menutop menusingle panel">
| + | |
- | <a class="panel" href="#software"><center>SOFTWARE TOOL<br /> BioGuide</Center></a>
| + | |
- | </div>
| + | |
- |
| + | |
- | </li>
| + | |
- | </ul></b>
| + | |
- | </div>
| + | |
- | | + | |
- | </body>
| + | |
- | | + | |
- | </html>
| + | |